Skip to main content
SpringerLink
Log in

Genital infection with human papillomavirus in adolescents

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections in adolescents. Such infection is associated with substantial health risks and is unpredictable in its resolution. Genital warts are the most common clinical manifestations of genital HPV infections. Most genital warts are caused by low-risk HPV types (notably HPV-6 and -11). The majority of genital HPV infections are latent or subclinical. Although the outcome of a genital HPV infection is variable, the infection is usually transient and complete resolution is common. However, persistent infections with high-risk HPV types (notably HPV-16 and -18) are associated with the development of cervical intraepithelial dysplasia (CIN), which may progress to cervical cancer. Genital warts, generally diagnosed in the clinic, can be treated with imiquimod, podofilox, podophyllin, liquid nitrogen, bichloroacetic or trichloroacetic acid, or surgery. Cervical cytology screening is an ideal screening test for subclinical HPV infection with resultant CIN. Annual cervical cytology screening should begin approximately 3 years after initiation of sexual intercourse but no later than age 21 years. Because of the high rate of regression of low-grade squamous intraepithelial lesions (LSIL) in adolescents, the cytologic study should be repeated within 6 to 12 months. Colposcopy should be reserved for persistent LSIL. Patients with high-grade squamous intraepithelial lesions (HSIL) should be referred for colposcopy and biopsy. Confirmed HSIL should be treated with cryotherapy, laser therapy, or loop electrosurgical excisional procedure. The use of therapeutic vaccines is still experimental. HPV infection can be prevented, to a certain extent, by delaying the initiation of sexual activity, limiting the number of sexual partners, and using latex condoms. Several viruslike particle candidate vaccines are under development for the prevention of HPV. These vaccines have been proven safe, well tolerated, highly immunogenic, and highly efficacious. Such vaccines are urgently needed and ultimately may be an important preventive measure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moscicki AB. Human papillomaviruses. In: Behrman RE, Kliegman RM, Jenson HB, eds.Nelson Textbook of Pediatrics. Philadelphia, Pa: WB Saunders; 2004:1084–1086.

    Google Scholar 

  2. Leung AK. Plantar wart.Can J Diagn. 1998;15:167–168.

    Google Scholar 

  3. Bartholomew DA. Human papillomavirus infection in adolescents: a rational approach.Adolesc Med. 2004;15:569–595.

    Article  Google Scholar 

  4. Lüdicke F, Stalberg A, Vassilakos P, et al. High- and intermediate-risk human papillomavirus infection in sexually active adolescent females.J Pediatr Adolesc Gynecol. 2001;14:171–174.

    Article  PubMed  Google Scholar 

  5. Kahn JA. An update on human papillomavirus infection and Papanicolaou smears in adolescents.Curr Opin Pediatr. 2001;13:303–309.

    Article  PubMed  CAS  Google Scholar 

  6. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of human papillomavirus type 16 vaccine.N Engl J Med. 2002;347:1645–1651.

    Article  PubMed  CAS  Google Scholar 

  7. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women.CMAJ. 2003;168:421–425.

    PubMed  Google Scholar 

  8. Vanchiere JA, Deminler GJ. Human papillomaviruses. In: Feigin RD, Cherry JD, Demmler GJ, eds.Textbook of Pediatric Infectious Diseases. Philadelphia, Pa: WB Saunders; 2004:1813–1831.

    Google Scholar 

  9. Bonnez W, Reichman RC. Papillomaviruses. In: Mandell GL, Bennett JE, Dolin R, eds.Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia, Pa: Churchill Livingstone; 2000:1630–1644.

    Google Scholar 

  10. Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents.Adolesc Med Clin. 2004;15:301–321.

    Article  PubMed  Google Scholar 

  11. Shah KV, McKenna K, Alexander KA. Human papillomaviruses. In: Long SS, Pickering LK, Prober CG, eds.Principles and Practice of Pediatric Infectious Diseases. New York, NY: Churchill Livingstone; 2003:1080–1084.

    Google Scholar 

  12. Rager KM, Kahn JA. Human papillomavirus and adolescent girls.Curr Women Health Rep. 2002;2:468–475.

    Google Scholar 

  13. Joffe A, Neinstein LS. Human papillomavirus (anogenital warts) and molluscum contagiosum. In: Neinstein LS, ed.Adolescent Health Care: A Practical Guide. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:1204–1211.

    Google Scholar 

  14. Tijong MY, Out TA, Schegget JT, et al. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review.Int J Gynecol Cancer. 2001;11:9–17.

    Article  Google Scholar 

  15. Irwin CE Jr, Shafer MA, Moscicki AB. Human papillomavirus. In: Rudolph CD, Rudolph AB, Hostetter MK, eds.Rudolph’s Pediatrics. New York, NY: McGraw-Hill; 2003:267–268.

    Google Scholar 

  16. Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to dessication.J Infect Dis. 1997; 176:1076–1079.

    PubMed  CAS  Google Scholar 

  17. Dunne EF, Burstein GR, Stone KM. Anogenital human papillomavirus infection in males.Adolesc Med. 2003;14:613–632.

    PubMed  Google Scholar 

  18. Ellen JM, Moscicki AB, Shafer MB. Genital herpes simplex virus and human papillomavirus infection.Adv Pediatr Infect Dis. 1994;9:97–124.

    PubMed  CAS  Google Scholar 

  19. Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection.Am J Obstet Gynecol. 2003;189:S3-S11.

    Article  PubMed  Google Scholar 

  20. Moscicki AB. Genital HPV infections in children and adolescents.Obstet Gynecol Clin North Am. 1996;23:675–697.

    PubMed  CAS  Google Scholar 

  21. Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults.J Pediatr. 1991;119:821–825.

    Article  PubMed  CAS  Google Scholar 

  22. Moscicki AB, Palefsky J, Gonzales J, et al. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors.Pediatr Res. 1990;28:507–513.

    Article  PubMed  CAS  Google Scholar 

  23. Rosenfeld WD, Vermund SH, Wentz SJ, et al. High prevalence rate of human papillomavirus infection and association with abnormal Papanicolaou smears in sexually active adolescents.Am J Dis Child. 1989;143:1443–1447.

    PubMed  CAS  Google Scholar 

  24. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.JAMA. 2002;288:1749–1757.

    Article  PubMed  Google Scholar 

  25. Duncan ME, Tibaux G, Pelzer A, et al. First coitus before menarche and risk of sexually transmitted disease.Lancet. 1990;335:338–340.

    Article  PubMed  CAS  Google Scholar 

  26. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnosis in northern New England.Pediatrics. 1999;103:539–545.

    Article  PubMed  CAS  Google Scholar 

  27. Shew ML, Fortenberry JD, Miles P, et al. Interval between menarche and first sexual intercourse, related to risk of human papillomavirus infection.J Pediatr. 1994;125:661–666.

    Article  PubMed  CAS  Google Scholar 

  28. Deligdisch L, de Resende Miranda CR, Wu HS, et al. Human papillomavirus-related cervical lesions in adolescents: a histologic and morphometric study.Gynecol Oncol. 2003;89:52–59.

    Article  PubMed  Google Scholar 

  29. Kahn JA, Rosenthal SL, Succop PA, et al. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection.Pediatrics. 2002;109:E5.

    Article  PubMed  Google Scholar 

  30. Hammerschlag MR, Rawstron SA. Human papillomavirus infection. In: Jensen HB, Baltimore RS, eds.Pediatric Infectious Diseases: Principles and Practice. Philadelphia, Pa: WB Saunders; 2002: 1029–1030.

    Google Scholar 

  31. American Academy of Pediatrics. Human papillomavirus. In: Pickering LK, ed.Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 2003:448–451.

    Google Scholar 

  32. Chuang TY, Perry HO, Kurland LT, et al. Condyloma acuminata in Rochester, Minn, 1950–1978: I. Epidemiology and clinical features.Arch Dermatol. 1984;120:469–475.

    Article  PubMed  CAS  Google Scholar 

  33. Leung AK, Robson WL. Condylomata accuminata.Resident Staff Physician. 1994;40:75.

    Google Scholar 

  34. Ho GYF, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women.N Engl J Med. 1998;338:423–428.

    Article  PubMed  CAS  Google Scholar 

  35. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.JAMA. 2001;285:2995–3002.

    Article  PubMed  CAS  Google Scholar 

  36. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.J Pediatr 1998;132:277–284.

    Article  PubMed  CAS  Google Scholar 

  37. Rousseau MC, Pereira JS, Prado JCM, et al. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.J Infect Dis. 2001; 184:1508–1517.

    Article  PubMed  CAS  Google Scholar 

  38. Kjaer SK, van den Brule AJC, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.BMJ. 2002;325:572–576.

    Article  PubMed  Google Scholar 

  39. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types should we vaccinate and screen? The international perspective.Int J Cancer. 2004;111:278–285.

    Article  PubMed  CAS  Google Scholar 

  40. Wallin KL, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.N Engl J Med. 1999;341:1633–1638.

    Article  PubMed  CAS  Google Scholar 

  41. Beutner KR, Richwald GA, Wiley DJ, et al. External genital warts: report of the American Medical Association Consensus Conference.Clin Infect Dis. 1998;27:796–806.

    Article  PubMed  CAS  Google Scholar 

  42. Bodemer C. Human papillomavirus. In: Schachner LA, Hansen RC, Happle R, et al, eds.Pediatric Dermatology. Edinburgh, Scotland: Mosby; 2003:1087–1090.

    Google Scholar 

  43. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system terminology for reporting results of cervical cytology.JAMA. 2002;287:2114–2119.

    Article  PubMed  Google Scholar 

  44. Nanda K, McCroy DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening and follow-up of cervical cytologic abnormalities: a systematic review.Ann Intern Med. 2000;132:810–819.

    PubMed  CAS  Google Scholar 

  45. Linder J, Zahniser D. The ThinPrep Pap test: a review of clinical studies.Acta Cytol. 1997;41:30–38.

    PubMed  CAS  Google Scholar 

  46. Sherlaw-Johnson C, Philips Z. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme.Br J Cancer. 2004;91:84–91.

    Article  PubMed  CAS  Google Scholar 

  47. Cox JT. Clinical role of HPV testing.Obstet Gynecol Clin North Am. 1996;23:811–851.

    Article  PubMed  CAS  Google Scholar 

  48. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary screening.Lancet. 1995;345:1533–1536.

    Article  PubMed  CAS  Google Scholar 

  49. Ledger WJ, Jeremias J, Witkin SS. Testing for high-risk human papillomavirus types will become a standard of clinical care.Am J Obstet Gynecol. 2000;182:860–865.

    Article  PubMed  CAS  Google Scholar 

  50. Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts.Am J Clin Pathol. 1994;2:768–774.

    Google Scholar 

  51. Cusini M, Salmaso F, Zerboni R, et al. 5% imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.Int J STD AIDS. 2004;15:17–20.

    Article  PubMed  CAS  Google Scholar 

  52. Sauder DN, Skinner RB, Fox TL, et al. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.Sex Transm Dis. 2003;30: 124–128.

    Article  PubMed  CAS  Google Scholar 

  53. Buck HW, Fortier M, Knudsen J, et al. Imiquimod 5% cream in the treatment of anogenital warts in female patients.Int J Gynecol Obstet. 2002;77:231–238.

    Article  CAS  Google Scholar 

  54. Majewski S, Pniewski T, Malejczyk M, et al. Imiquimod is highly effective for extensive, hyperproliferative condyloma in children.Pediatr Dermatol. 2003;20:440–442.

    Article  PubMed  Google Scholar 

  55. American College of Obstetricians and Gynecologists. Practice Bulletin No. ACOG45: Cervical cytology screening.Obstet Gynecol. 2003;102:417–427.

    Article  Google Scholar 

  56. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer.Cancer J Clin. 2002;52:342–362.

    Article  Google Scholar 

  57. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities.JAMA. 2002; 287:2120–2129.

    Article  PubMed  Google Scholar 

  58. Peng S, Ji H, Trimble C, et al. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.J Virol. 2004;78:8468–8476.

    Article  PubMed  CAS  Google Scholar 

  59. Frazer IH, Quinn M, Nicklin JL, et al. Phase 1 study of HPV 16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia.Vaccine. 2004;23:172–181.

    Article  PubMed  CAS  Google Scholar 

  60. Baldwin PJ, van der Burg SH, Boswell CM, et al. Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.Clin Cancer Res. 2003;9:5205–5213.

    PubMed  CAS  Google Scholar 

  61. Ault KA, Giuliano AR, Edwards RP, et al. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.Vaccine. 2004;22:3004–3007.

    Article  PubMed  CAS  Google Scholar 

  62. Fife KH, Wheeler CM, Koutsky LA, et al. Dose-ranging studies of the safety and immunogenicity of human papillomavirus type 11 and type 16 virus-like particle candidate vaccines in young healthy women.Vaccine. 2004;22:2943–2952.

    Article  PubMed  CAS  Google Scholar 

  63. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.Lancet. 2004;364:1757–1765.

    Article  PubMed  CAS  Google Scholar 

  64. Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year old adolescents.Obstet Gynecol Surv. 2004;59:820–822.

    Article  Google Scholar 

  65. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescents/young adult women toward human papillomavirus vaccination and clinical trials.Health Care Women Int. 2000;21:375–391.

    Article  PubMed  CAS  Google Scholar 

  66. Kahn JA, Rosenthal S, Hamann T, et al. Attitudes about human papillomavirus vaccine in young women.Int J STD AIDS. 2003;14:300–306.

    Article  PubMed  Google Scholar 

  67. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, et al. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico.Arch Med Res. 2001; 32:243–247.

    Article  PubMed  CAS  Google Scholar 

  68. Health Canada, Health Protection Branch, Laboratory Centre for Disease Control. Cervical Cancer in Canada 1999. Available at: http://www.hc-sc.gc.ca/hpb/lcdc/bc/updates/ cervix_e.htm.

  69. Stuart GCE, Parboosingh J. Implementation of comprehensive screening for cervical cancer in Canada: impediments and facilitators.J Soc Obstet Gynecol Canada. 1996;18:1241–1250.

    Google Scholar 

  70. Feoli-Fonseca JC, Oligny LL, Brochu P, et al. Human papillomavirus study of 691 pathology specimens from Quebec by PCR-direct sequencing approach.J Med Virol. 2001;63:284–292.

    Article  PubMed  CAS  Google Scholar 

  71. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papillomavirus vaccine.Epidemiology. 2002;13:631–639.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Calgary Alberta Children’s Hospital, Calgary, Alberta, Canada

    Alexander K. C. Leung MBBS, FRCPC, FRCPI, FRCPCH & James D. Kellner MD, FRCPC

  2. Department of Pediatrics of Human Development, Michigan State University, East Lansing, Michigan

    H. Dele Davies MD, FRCPC

Authors
  1. Alexander K. C. Leung MBBS, FRCPC, FRCPI, FRCPCH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James D. Kellner MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Dele Davies MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, A.K.C., Kellner, J.D. & Davies, H.D. Genital infection with human papillomavirus in adolescents. Adv Therapy 22, 187–197 (2005). https://doi.org/10.1007/BF02849928

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02849928

Keywords

Search

Navigation